Expanded Use of Imbruvica Approved

The FDA has approved the expanded use of Imbruvica (ibrutinib; Pharmacyclics and Janssen Biotech) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion).

New Oral Doxycycline Formulation Approved

The FDA has approved the New Drug Application (NDA) for Acticlate (doxycycline hyclate) for the treatment of susceptible infections including adjunctive therapy in severe acne.

Bariatric Surgery Improves Urinary Incontinence

For obese women with prevalent urinary incontinence (UI), the frequency of UI episodes is reduced during three years of follow-up after bariatric surgery.

Sodium Intake Linked to CVD in T2DM

For patients with type 2 diabetes, high dietary sodium intake is associated with cardiovascular disease (CVD).